Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Pharma-Bio Serv, Inc. shareholders approved Ratification of Crowe PR PSC as independent auditors at the 2023-05-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-05-31
Exact text from the filing
The ratification of the selection of Crowe PR PSC as the Company's independent certified public accountants for the fiscal year ending October 31, 2023 received the following votes: Votes For Votes Against Abstain 14,344,226 1,492,688 3,852,921 There were no broker non-votes on this proposal.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Pharma-Bio Serv, Inc. shareholders approved Election of Irving Wiesen as a Class I director at the 2023-05-31 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-05-31
Exact text from the filing
Irving Wiesen was elected as a Class I director by a plurality of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote. Mr. Wiesen shall serve as a Class I director until the 2026 Annual Meeting of Stockholders or until his successor is duly elected and qualified. The votes for this proposal were as follows: Nominee Votes For Votes Withheld Irving Wiesen 7,477,036 11,696,947 There were 515,852 broker non-votes on this proposal.
View on SEC.gov